Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-04
DOI
10.1007/s00213-022-06201-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The influence of ketamine’s repeated treatment on brain topology does not suggest an antidepressant efficacy
- (2020) Natalia Gass et al. Translational Psychiatry
- Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation
- (2020) Tahir Ali et al. JOURNAL OF PINEAL RESEARCH
- Global Burden of Disease and the Impact of Mental and Addictive Disorders
- (2019) Jürgen Rehm et al. Current Psychiatry Reports
- Honokiol-Mediated Mitophagy Ameliorates Postoperative Cognitive Impairment Induced by Surgery/Sevoflurane via Inhibiting the Activation of NLRP3 Inflammasome in the Hippocampus
- (2019) Ji-Shi Ye et al. Oxidative Medicine and Cellular Longevity
- Interplay between Mitophagy and inflammasome in Neurological Disorders
- (2019) Radhika Kesharwani et al. ACS Chemical Neuroscience
- Involvement of the microglial NLRP3 inflammasome in the anti-inflammatory effect of the antidepressant clomipramine
- (2019) Wenqing Gong et al. JOURNAL OF AFFECTIVE DISORDERS
- Andrographolide triggers autophagy-mediated inflammation inhibition and attenuates chronic unpredictable mild stress (CUMS)-induced depressive-like behavior in mice
- (2019) Ji Geng et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?
- (2018) Michael Berk et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- The antidepressant effects of ɑ-tocopherol are related to activation of autophagy via the AMPK/mTOR pathway
- (2018) Xiaoyan Huang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Sucrose preference test for measurement of stress-induced anhedonia in mice
- (2018) Meng-Ying Liu et al. Nature Protocols
- Ketamine induces hippocampal apoptosis through a mechanism associated with the caspase-1 dependent pyroptosis
- (2018) Zhi Ye et al. NEUROPHARMACOLOGY
- Administration of Ketamine Causes Autophagy and Apoptosis in the Rat Fetal Hippocampus and in PC12 Cells
- (2018) Xinran Li et al. Frontiers in Cellular Neuroscience
- Ketamine induces reactive oxygen species and enhances autophagy in SV-HUC-1 human uroepithelial cells
- (2018) Zhengfei Shan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
- (2018) Yan Yang et al. NATURE
- Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors
- (2018) Jia-Mei Li et al. NEUROPHARMACOLOGY
- NLRP3 inflammasome activation contributes to long-term behavioral alterations in mice injected with lipopolysaccharide
- (2017) Wei Zhu et al. NEUROSCIENCE
- Posttraumatic administration of a sub-anesthetic dose of ketamine exerts neuroprotection via attenuating inflammation and autophagy
- (2017) C.-Q. Wang et al. NEUROSCIENCE
- A brief history of the development of antidepressant drugs: From monoamines to glutamate.
- (2015) Todd M. Hillhouse et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Two Chronic Stress Models Based on Movement Restriction in Rats Respond Selectively to Antidepressant Drugs: Aldolase C As a Potential Biomarker
- (2015) Estibaliz Ampuero et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome
- (2015) Elísabet Alcocer-Gómez et al. MOLECULAR NEUROBIOLOGY
- Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats
- (2014) Ying Pan et al. BRAIN BEHAVIOR AND IMMUNITY
- NLRP3 Inflammasome: A New Target in Major Depressive Disorder
- (2014) Elísabet Alcocer-Gómez et al. CNS Neuroscience & Therapeutics
- The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
- (2014) Gianluca Serafini et al. Current Neuropharmacology
- Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia
- (2014) N. Yuan et al. HAEMATOLOGICA
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
- (2014) David A. Mrazek et al. PSYCHIATRIC SERVICES
- Ketamine Enhances Human Neural Stem Cell Proliferation and Induces Neuronal Apoptosis via Reactive Oxygen Species–Mediated Mitochondrial Pathway
- (2013) Xiaowen Bai et al. ANESTHESIA AND ANALGESIA
- NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder
- (2013) Elísabet Alcocer-Gómez et al. BRAIN BEHAVIOR AND IMMUNITY
- Interleukin-1β is associated with depressive episode in major depression but not in bipolar disorder
- (2013) Rosana Mota et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
- (2013) Ian Mahar et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Treatment-Resistant Depression Increases Health Costs and Resource Utilization
- (2013) Beatrice Alinka Lepine et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- A Single Subanesthetic Dose of Ketamine Relieves Depression-like Behaviors Induced by Neuropathic Pain in Rats
- (2011) Jing Wang et al. ANESTHESIOLOGY
- Antidepressant Drugs Diversely Affect Autophagy Pathways in Astrocytes and Neurons—Dissociation from Cholesterol Homeostasis
- (2011) Jürgen Zschocke et al. NEUROPSYCHOPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started